Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow et al. · Diabetes Care · 2008 · 884 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Roy W. Beck, Richard M. Bergenstal, Tonya D. Riddlesworth et al. · Diabetes Care · 2018 · 775 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Hypoglycemia in the Diabetes Control and Complications Trial

Diabetes · 1997 · 752 citations

Medicine, Internal Medicine, Communication In Serious Illness +12

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

Jingyi Lu, Xiaojing Ma, Jian Zhou et al. · Diabetes Care · 2018 · 511 citations

Medicine, Internal Medicine, Ophthalmology +17

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

Kellee M. Miller, Roy W. Beck, Richard M. Bergenstal et al. · Diabetes Care · 2013 · 500 citations · Full text

Medicine, Endocrinology, Diabetology +16